{"filing":{"accession_number":"0001140361-26-022311","cik":"0001281895","ticker":"RCKTW","company_name":"ROCKET PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"ef20074449_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022311/ef20074449_8k.htm"},"events":[{"id":9349,"run_id":8202,"accession_number":"0001140361-26-022311","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on May 20, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of the independent auditor (EisnerAmper LLP), advisory vote on named executive officer compensation, and approval of a stock option exchange program. The detailed vote tallies for each proposal and nominee are the hallmark of shareholder_vote_results classification.","company_name":"ROCKET PHARMACEUTICALS, INC.","ticker":"RCKTW","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":957,"accession_number":"0001140361-26-022311","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on May 20, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of the independent auditor (EisnerAmper LLP), advisory vote on named executive officer compensation, and approval of a stock option exchange program. The detailed vote tallies for each proposal and nominee are the hallmark of shareholder_vote_results classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:34:09.451722+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":957,"accession_number":"0001140361-26-022311","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on May 20, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of the independent auditor (EisnerAmper LLP), advisory vote on named executive officer compensation, and approval of a stock option exchange program. The detailed vote tallies for each proposal and nominee are the hallmark of shareholder_vote_results classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:34:09.451722+00:00","company_name":"ROCKET PHARMACEUTICALS, INC.","ticker":"RCKTW","filing_date":"2026-05-21"}]}